Search For "dr reddy"
Equity indices close in the red, Reliance falters by 4 pc
Updated : 6 years ago IST
Mumbai (Maharashtra) [India], July 29 (ANI): Equities came under heavy selling pressure in the afternoon session on Wednesday with benchmark indices slipping by 1 per cent amid mixed cues in global markets.
Read More
Dr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter
Updated : 6 years ago IST
Hyderabad (Telangana) [India], July 29 (ANI): Dr Reddy's Laboratories on Wednesday reported 13 per cent fall in its net profit at Rs 579 crore against during the April to June quarter compared to Rs 663 crore in the year-ago period.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 6 years ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Six Indian companies applied to CDSCO for permission to manufacture, marke
Updated : 6 years, 1 month ago IST
New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR, Jubilant, Mylan and Dr Reddy's Labs -- have applied to Indian Drug Regulatory Agency, Central Drug Standard Control Organisation (CDSCO) for permission to manufacture and market the R
Read More
Dr Reddy's Labs in licensing pact with Gilead Sciences for Remdesivir
Updated : 6 years, 1 month ago IST
Hyderabad (Telangana) [India], June 13 (ANI): Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc that will grant Dr Reddy's the right to register, manufacture and sell Gilead's investigational drug Remdesivir, a potent
Read More
Dr Reddy's completes acquisition of Wockhardt's select business divisions
Updated : 6 years, 1 month ago IST
Hyderabad (Telangana) [India], June 10 (ANI): Dr Reddy's Laboratories said on Wednesday it has completed the acquisition of select divisions of Wockhardt Ltd's branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives.
Read More
Equity gauges up in early trading, pharma stocks gain
Updated : 6 years, 1 month ago IST
Mumbai (Maharashtra) [India], June 9 (ANI): Equity benchmark indices gained during early hours on Tuesday in volatile trading with pharma stocks leading the rally.
Read More
Equity indices hold firm, pharma and financial stocks up
Updated : 6 years, 2 months ago IST
Mumbai (Maharashtra) [India], May 20 (ANI): Equity benchmark indices gained for the second consecutive day on Wednesday as heavy buying was witnessed in pharma and financial stocks.
Read More
Dr Reddy's Q4 profit jumps 76 pc to Rs 764 crore on higher sales in US, Eu
Updated : 6 years, 2 months ago IST
Hyderabad (Telangana) [India], May 20 (ANI): Dr Reddy's Laboratories Ltd on Wednesday reported a net profit of Rs 764 crore during the January to March quarter, up 76 per cent from Rs 434 crore in the corresponding quarter of the previous financial year.
Read More
Wockhardt's profitability for Q4 improves to Rs 48 crore
Updated : 6 years, 2 months ago IST
Mumbai (Maharashtra) [India], May 11 (ANI): Pharmaceutical and biotechnology major Wockhardt on Monday reported a profit after tax of Rs 48 crore in Q4 FY20 as against a loss of Rs 15 crore in the corresponding period of last year.
Read More
Ind-Ra assigns A1-plus rating to Dr Reddy's commercial papers
Updated : 6 years, 3 months ago IST
Mumbai (Maharashtra) [India], May 2 (ANI): India Ratings and Research (Ind-Ra) has accorded AA-plus rating to Dr Reddy's Laboratories Ltd's (DRL's) long-term issuer rating with stable outlook and A1-plus to commercial papers.
Read More
UPS adds over 200 flights in April to support Project Airbridge coronaviru
Updated : 6 years, 3 months ago IST
Mumbai (Maharashtra) [India], April 21 (ANI/NewsVoir): UPS India helped Dr. Reddy's Laboratories ship critical compounds for essential medicines to the United States. UPS (NYSE:UPS) said it has added over 200 company-owned and chartered air freighter flights in April to support FEMA's Projec
Read More